Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.

Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays Revision: v3.6.3 in place of Revision: v3.6.0, indicating a small underlying update to the page.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedEnrollment status now indicates recruitment has ended. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the Intervention/Treatment heading formatting, and includes a site revision tag (Revision: v3.6.0).SummaryDifference0.1%

- Check40 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a newer version of the study record on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3, indicating an updated version of the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe THALES study locations list was updated to replace Liuchow, China with Liuzhou, China (545006) and Malmo, Sweden with Malmö, Sweden (205 02). The additions reflect updated spellings and postal codes for the two sites.SummaryDifference0.0%

- Check84 days agoChange DetectedUpdated the displayed system/app revision identifier from **v3.5.2** to **v3.5.3** on the page footer.SummaryDifference0.0%

Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.